CV Sciences Inc (OTCMKTS:CVSI) is possibly beginning to show some renewed signs of life following a period of heavy doubt that was initially sparked by a...
CV Sciences Inc (OTCMKTS:CVSI) has announced its financial results for the fourth quarter and year ended December 31, 2017. The company reported sales of $7.2 million...
CV Sciences Inc (OTCMKTS:CVSI) announced recently that it has repaid the April 2018 installment obligation on its Convertible Promissory Note in cash to avoid the lender...
CV Sciences Inc (OTCMKTS:CVSI) reported that it will be showcasing its industry-leading brand of hemp-derived Cannabidiol oil finished offerings, PlusHemp Oil™, at this year’s Integrative Health...
CV Sciences Inc (OTCMKTS:CVSI) reported that it will be showcasing at the 25th A4M event, to be held from December 14 to December 16, 2017 at...
CV Sciences Inc (OTCMKTS:CVSI) reported that it has retired the December 2017 installment due under its March 1, 2017 “Note” in cash, hence avoiding the financier’s...
In the last trading session, the stock price of General Cannabis Corp (OTCMKTS:CANN) jumped more than 29% to close the day at $2.89. As per a...
In the last trading session, the stock price of CV Sciences Inc (OTCMKTS:CVSI) declined more than 2% to close the day at $0.231. The decline came...
CV Sciences Inc (OTCMKTS:CVSI) issued its financial report for the third quarter closed September 30, 2017. The company posted record quarterly sales of around $5.591 million,...
CV Sciences Inc (OTCMKTS:CVSI) has repaid and satisfied all dues under its Convertible Promissory Note, May 25, 2016. The firm released the Note last year on...